HYPOTHESIS: TETRACYCLINES FOR SEVERE COVID-19 – THE PERFECT REPURPOSING CANDIDATE?

Garrido-Mesa J*1, Adams KE2, Galvez J3, Garrido-Mesa N4
1Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, Guy’s & St Thomas’ NHS Foundation Trust and King’s College London NIHR Biomedical Research Centre, London, UK.
2Department of Bioscience, School of Health, Sport and Bioscience, University of East London, London, UK.
3 Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, AND Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
4Department of Pharmacy, School of Life Sciences, Pharmacy and Chemistry. Kingston University, London, UK.
*Correspondence :  Jose Garrido Mesa, PhD
Spondyloarthritis Research Group, Department of Medical & Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences & Medicine​, King’s College London. Email: j.garrido@kcl.ac.uk (J. Garrido-Mesa).